Vu H. Duong

TGF-β-RI Kinase Inhibitor SD-208 Reduces the Development and Progression of Melanoma Bone Metastases

Khalid S. Mohammad, Delphine Javelaud, Pierrick G.J. Fournier et al. · Cancer Research · 2010 · 217 citations · Full text

Melanoma Cell Lines, Tumor Biology, Bone Morphogenic Protein +14

Enhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents – A Potential Therapy for Cancer

Nidal Muvarak, Khadiza Chowdhury, Limin Xia et al. · Cancer Cell · 2016 · 207 citations · Full text

Cytotoxic Effects, A Potential Therapy, Medicine +8

Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial

Amy Burd, Ross L. Levine, Amy S. Ruppert et al. · Nature Medicine · 2020 · 181 citations · Full text

Hematological Malignancy, Prospective Genomic Profiling, Oncology +13

Ten-day decitabine as initial therapy for newly diagnosed patients with acute myeloid leukemia unfit for intensive chemotherapy

Bhavana Bhatnagar, Vu H. Duong, Theodore Stewart Gourdin et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2013 · 56 citations

Mixed-phenotype Acute Leukemia, Pharmacotherapy, Myeloid Neoplasia +19

Asparaginase Erwinia chrysanthemi effectively depletes plasma glutamine in adult patients with relapsed/refractory acute myeloid leukemia

Ashkan Emadi, Jennie Y. Law, Erin T. Strovel et al. · Cancer Chemotherapy and Pharmacology · 2017 · 53 citations

Plasma Glutamine, Medicine, Adult Patients +4